
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changming Wang, Jiapeng Xu, Hongbing Fu, et al.
Journal of Cellular and Molecular Medicine (2018) Vol. 22, Iss. 10, pp. 5020-5028
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
TRIM family contribute to tumorigenesis, cancer development, and drug resistance
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 86
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 86
E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis
Santina Venuto, Giuseppe Merla
Cells (2019) Vol. 8, Iss. 5, pp. 510-510
Open Access | Times Cited: 128
Santina Venuto, Giuseppe Merla
Cells (2019) Vol. 8, Iss. 5, pp. 510-510
Open Access | Times Cited: 128
The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11
Qishuai Chen, Tong-Tong Zhang, Runzhi Zeng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Qishuai Chen, Tong-Tong Zhang, Runzhi Zeng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 50
Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 50
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 40
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 40
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer
Jianming Tang, Jing Li, Jiayan Lian, et al.
Journal of Advanced Research (2023) Vol. 61, pp. 239-251
Open Access | Times Cited: 11
Jianming Tang, Jing Li, Jiayan Lian, et al.
Journal of Advanced Research (2023) Vol. 61, pp. 239-251
Open Access | Times Cited: 11
Quercetin alleviates kidney damage caused by mercury Chloride: The protective effects of quercetin on autophagy and inflammation were studied based on TRIM32/TLR4/LC3 pathway
Jin Fan, J. Z. Li, Chenyu Zhao, et al.
Toxicon (2024) Vol. 248, pp. 108031-108031
Closed Access | Times Cited: 4
Jin Fan, J. Z. Li, Chenyu Zhao, et al.
Toxicon (2024) Vol. 248, pp. 108031-108031
Closed Access | Times Cited: 4
TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation
Jian‐Jun Wang, Yuejun Fang, Tao Liu
BioMed Research International (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 31
Jian‐Jun Wang, Yuejun Fang, Tao Liu
BioMed Research International (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 31
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases
Nieves Lara-Ureña, Vahid Jafari, Mario García‐Domínguez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8012-8012
Open Access | Times Cited: 18
Nieves Lara-Ureña, Vahid Jafari, Mario García‐Domínguez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8012-8012
Open Access | Times Cited: 18
TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1
Katrine Stange Overå, Juncal Garcia‐Garcia, Zambarlal Bhujabal, et al.
Journal of Cell Science (2019) Vol. 132, Iss. 23
Open Access | Times Cited: 26
Katrine Stange Overå, Juncal Garcia‐Garcia, Zambarlal Bhujabal, et al.
Journal of Cell Science (2019) Vol. 132, Iss. 23
Open Access | Times Cited: 26
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells
Xiaoxia Shi, Yixin Du, Shujing Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3639-3639
Open Access | Times Cited: 15
Xiaoxia Shi, Yixin Du, Shujing Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3639-3639
Open Access | Times Cited: 15
The Role of Tripartite Motif Family Proteins in TGF-β Signaling Pathway and Cancer
Ho-Jae Lee
Journal of Cancer Prevention (2018) Vol. 23, Iss. 4, pp. 162-169
Open Access | Times Cited: 25
Ho-Jae Lee
Journal of Cancer Prevention (2018) Vol. 23, Iss. 4, pp. 162-169
Open Access | Times Cited: 25
TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination
Xiaowen Liu, Ziwen Long, Hong Cai, et al.
Cancer Biology & Therapy (2019) Vol. 21, Iss. 3, pp. 203-212
Open Access | Times Cited: 24
Xiaowen Liu, Ziwen Long, Hong Cai, et al.
Cancer Biology & Therapy (2019) Vol. 21, Iss. 3, pp. 203-212
Open Access | Times Cited: 24
Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance
Huizhen Wang, Yida Lu, Mingliang Wang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 2, pp. 193-212
Closed Access | Times Cited: 19
Huizhen Wang, Yida Lu, Mingliang Wang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 2, pp. 193-212
Closed Access | Times Cited: 19
TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway
Zhao Chen, Lifang Tian, Li Wang, et al.
Inflammation (2021) Vol. 45, Iss. 3, pp. 992-1006
Closed Access | Times Cited: 18
Zhao Chen, Lifang Tian, Li Wang, et al.
Inflammation (2021) Vol. 45, Iss. 3, pp. 992-1006
Closed Access | Times Cited: 18
TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1
Chao Gu, Yiwen Xia, Chen Lu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3656-3674
Open Access | Times Cited: 2
Chao Gu, Yiwen Xia, Chen Lu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3656-3674
Open Access | Times Cited: 2
TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers
Yaming Du, Wei Zhang, Binghui Du, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 7841-7852
Open Access | Times Cited: 19
Yaming Du, Wei Zhang, Binghui Du, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 7841-7852
Open Access | Times Cited: 19
Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis
Qingjie Meng, Linlin Wang, Yonggang Lv, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 1, pp. 23-35
Closed Access | Times Cited: 17
Qingjie Meng, Linlin Wang, Yonggang Lv, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 1, pp. 23-35
Closed Access | Times Cited: 17
<p>Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin</p>
Xueliang Su, Bangjie Wang, Yehong Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 277-289
Open Access | Times Cited: 16
Xueliang Su, Bangjie Wang, Yehong Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 277-289
Open Access | Times Cited: 16
TRIM proteins in breast cancer: Function and mechanism
Xin De Bai, Jianming Tang
Biochemical and Biophysical Research Communications (2022) Vol. 640, pp. 26-31
Closed Access | Times Cited: 10
Xin De Bai, Jianming Tang
Biochemical and Biophysical Research Communications (2022) Vol. 640, pp. 26-31
Closed Access | Times Cited: 10
TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
Jiajia Hu, Runjie Huang, Chengcai Liang, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 10, pp. 1107-1119
Open Access | Times Cited: 6
Jiajia Hu, Runjie Huang, Chengcai Liang, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 10, pp. 1107-1119
Open Access | Times Cited: 6
TRIM proteins in fibrosis
Hao Qian, Lijuan Chen
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112340-112340
Open Access | Times Cited: 14
Hao Qian, Lijuan Chen
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112340-112340
Open Access | Times Cited: 14
Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner
Yu Cai, Wei Gu, Kang Cheng, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 134-141
Closed Access | Times Cited: 12
Yu Cai, Wei Gu, Kang Cheng, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 134-141
Closed Access | Times Cited: 12
TRIM proteins in neuroblastoma
Yonghu Xu, Zihan Zhang, Guofeng Xu
Bioscience Reports (2019) Vol. 39, Iss. 12
Open Access | Times Cited: 12
Yonghu Xu, Zihan Zhang, Guofeng Xu
Bioscience Reports (2019) Vol. 39, Iss. 12
Open Access | Times Cited: 12